Our products are challenging to develop and manufacture with complexities arising from formulation & process development, regulatory hurdles, stability and scale up. In addition, since a majority of our products in development have multiple scientific and manufacturing hurdles competition is limited. Such products offer a niche market opportunity for Solaris Pharma Corporation.
 
Solaris Pharma Corporation benefits from its technical expertise in the development of specialized generic & branded complex pharmaceutical products many of which have significant scientific and regulatory hurdles. With its committed and well-trained scientific personnel, Solaris Pharma Corporation is currently developing several products in the sterile, topical, tablet dosage forms among others, which are in different stages of development.